drugset / Trial / NCT01719614
A Study to Explore Pharmacokinetic Interaction Between Rilpivirine and Metformin in Healthy Participants
NaSingle-groupOpen-labelTreatment
Summary
The purpose of the study is to evaluate the effect of steady-state (constant concentration of medication in the blood) rilpivirine on pharmacokinetics (how a single dose of metformin is absorbed in the body, distributed within the body, and removed from the body) of a single dose of metformin, over time, in healthy adult participants.
Timeline
- Start
- 2012-10
- Primary completion
- 2013-01
- Completion
- 2013-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Metformin | Small molecule | 850 mg | Oral |
| Subject | Rilpivirine | Small molecule | 25 mg | Oral |
Indications
No indication recorded.